Dr. Arthur Kavanaugh: ACR Wrap-Up
Dr. Kavanaugh recaps abstracts 661, 1112, 2031 and 2032 at the ACR/ARHP Annual Meeting in San Diego.
Dr Jack Cush: Stills and Auto-Inflammatory Syndromes
Dr. Jack Cush discusses autoinflammatory syndomes at the ACR/ARHP Annual Meeting in San Diego.
Dr. Philip Robinson: Osteoarthritis and Inflammation
Dr. Philip Robinson discusses several studies that address OA and inflammation at the ACR/ARHP Annual Meeting in San Diego.
Dr. Rachel Tate: Ultrasound Education
Dr. Rachel Tate discusses the Year in Review on medical education and the need for ultrasound education at the ACR/ARHP Annual Meeting in San Diego.
Dr. Alvin Wells: Telemedicine
Dr. Alvin Wells discuss data presented on telemedicine, telehealth and telemedicine at the ACR/ARHP Annual Meeting in San Diego.
Dr. Shashank Akerkar: New Molecules in Psoriatic Arthritis
Dr. Shashank Akerkar discusses new molecules in psoriatic arthritis at the ACR/ARHP Annual Meeting in San Diego.
Dr. Janet Pope: Therapy Effect on Radiographic Progression
Dr. Janet Pope discusses abstract 3377 regarding radiographic change at the ACR/ARHP Annual Meeting in San Diego.
A number of presentations over the past few days have addressed the health economics of SLE.
While the incidence of pneumocystis pneumonia (PJP) is low is patients with rheumatologic diseases the mortality is quite high compared to PJP in patients with HIV and infection can be prevented with appropriate prophylaxis.
Dr. Eric Ruderman: Impact of Prior Authorization on Prescriptions
Dr. Eric Ruderman discusses the impact of prior authorization on prescription medications at the ACR/ARHP Annual Meeting in San Diego.
In this session we were given new data on ustekinumab for SLE (abstract 6L). Ustekinumab is an IL12/23 agent already approved for use in psoriasis, psoriatic arthritis and Cohn’s disease.
Dr. Janet Pope: Interstitial Lung Disease and RA
Dr. Janet Pope discussed ILD and RA at the ACR/ARHP Annual Meeting in San Diego.
Dr. Len Calabrese: Herpes Zoster
Dr. Len Calabrese discusses herpes zoster at the ACR/ARHP Annual Meeting in San Diego.
Dr. Julio Gonzalez: Radiographic Progression in Psoriatic Arthritis
Dr. Julio Gonzalez discusses three studies about radiographic progression in psoriatic arthritis at the ACR/ARHP Annual Meeting in San Diego.
In the registration trials for febuxostat there were concerns about a cardiovascular (CV) safety signal. In studies of the effect of allopurinol on CV risk/events allopurinol has found to be protective so whether febuxostat is different is a point to clarify.
